Amivantamab monotherapy and in combination with lazertinib in post-osimertinib EGFR-mutant NSCLC: Analysis from the CHRYSALIS study
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Leighl, N. B.
Shu, C. A.
Minchom, A.
Felip, E.
Cousin, S.
Cho, B. C.
Park, K.
Han, J-Y.
Boyer, M.
Lee, C. K.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
